| scholarly article | Q13442814 |
| P50 | author | David C. Christiani | Q30069760 |
| Mariza de Andrade | Q42067404 | ||
| Zhifu Sun | Q47119878 | ||
| Chau-Chyun Sheu | Q57018386 | ||
| Zuo-Feng Zhang | Q57419786 | ||
| Julie M. Cunningham | Q67440680 | ||
| P2093 | author name string | Feng Chen | |
| Li Su | |||
| Ping Yang | |||
| Yan Li | |||
| Jin Jen | |||
| Hui Tang | |||
| V Shane Pankratz | |||
| George Vasmatzis | |||
| Liang Wang | |||
| Mark S Allen | |||
| Jie Lin | |||
| Margaret R Spitz | |||
| Xifeng Wu | |||
| Yuanqing Ye | |||
| Yafei Li | |||
| Claude Deschamps | |||
| Curtis C Harris | |||
| Shen-Chih Chang | |||
| Ruoxiang Jiang | |||
| Marie C Aubry | |||
| Randolph S Marks | |||
| Jeremiah A Aakre | |||
| Renyi Wang | |||
| P2860 | cites work | Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 Mb region of 13q32-33 | Q74576339 |
| Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003 | Q80345591 | ||
| Health consequences of sustained smoking cessation | Q83379091 | ||
| Phenotype and 244k array-CGH characterization of chromosome 13q deletions: an update of the phenotypic map of 13q21.1-qter | Q83641039 | ||
| Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum | Q21145030 | ||
| Population structure and eigenanalysis | Q21145248 | ||
| Glypicans | Q21183908 | ||
| Lung cancer risk and workplace exposure to environmental tobacco smoke | Q23916899 | ||
| Common 5p15.33 and 6p21.33 variants influence lung cancer risk | Q24646182 | ||
| Somatic mutations affect key pathways in lung adenocarcinoma | Q24648102 | ||
| Lung cancer susceptibility locus at 5p15.33 | Q24649980 | ||
| Revealing the architecture of gene regulation: the promise of eQTL studies | Q24657564 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| Glypicans in growth control and cancer | Q28185369 | ||
| Developmental roles of the glypicans | Q28211145 | ||
| Lung cancer in never smokers: a review | Q28287500 | ||
| Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family | Q28305988 | ||
| Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis | Q28943261 | ||
| Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 | Q28943480 | ||
| Common regulatory variation impacts gene expression in a cell type-dependent manner | Q29614882 | ||
| A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 | Q29614944 | ||
| Lung cancer in never smokers--a different disease | Q29615414 | ||
| Genetic analysis of genome-wide variation in human gene expression | Q29617852 | ||
| Wnt signalling and its impact on development and cancer | Q29619273 | ||
| Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme | Q31114297 | ||
| Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | Q33320978 | ||
| A rigorous and comprehensive validation: common genetic variations and lung cancer | Q33586584 | ||
| Heparan sulfate proteoglycans and cancer. | Q34441253 | ||
| Modifying risk of developing lung cancer by changing habits of cigarette smoking | Q34551015 | ||
| Second hand smoke, age of exposure and lung cancer risk | Q34587020 | ||
| Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. | Q34736044 | ||
| Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene | Q34974643 | ||
| Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers | Q35015670 | ||
| Lung cancer in never-smokers | Q36026075 | ||
| Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk | Q36926072 | ||
| Genetic similarities between organogenesis and tumorigenesis of the lung. | Q37078785 | ||
| Lung cancer epigenetics and genetics | Q37143369 | ||
| Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer | Q39451329 | ||
| Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers | Q40285059 | ||
| Faster cyclic loess: normalizing RNA arrays via linear models | Q50774624 | ||
| Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma. | Q55475292 | ||
| Prospective study of smoking, antioxidant intake, and lung cancer in middle-aged women (USA) | Q57751041 | ||
| Comparative genomic hybridization detects novel amplifications in fibroadenomas of the breast | Q57791027 | ||
| Gene Expression in Lung Adenocarcinomas of Smokers and Nonsmokers | Q60609569 | ||
| Lung Cancer Risk Reduction After Smoking Cessation: Observations From a Prospective Cohort of Women | Q61670391 | ||
| P4510 | describes a project that uses | genome-wide association study | Q1098876 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| genome-wide association study | Q1098876 | ||
| P304 | page(s) | 321-330 | |
| P577 | publication date | 2010-03-19 | |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | Genetic variants and risk of lung cancer in never smokers: a genome-wide association study | |
| P478 | volume | 11 |
| Q92345986 | A Hidden Epidemic of "Intermediate Risk" Oropharynx Cancer |
| Q38671004 | A decade of GWAS results in lung cancer. |
| Q83595575 | A lung cancer gene GPC5 could also be crucial in breast cancer |
| Q38211430 | A symbiotic liaison between the genetic and epigenetic code |
| Q41082130 | A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses. |
| Q34031242 | Acetylcholine receptor pathway in lung cancer: New twists to an old story |
| Q55431061 | Advances in early diagnosis of lung cancer |
| Q43159134 | Analysis of susceptible genes and chromosome loci for lung cancers by automated gene prediction tools and genome scanning meta-analysis |
| Q37941513 | Antithetic roles of proteoglycans in cancer. |
| Q98386137 | Artificial intelligence powered statistical genetics in biobanks |
| Q22122086 | Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population |
| Q41980732 | Association between Interleukin-1β Gene -511C>T/+3954C>T Polymorphisms and Aggressive Periodontitis Susceptibility: Evidence from a Meta-Analysis |
| Q37879972 | Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis |
| Q34449854 | Attributing effects to interactions |
| Q38844239 | Biomarker development in the precision medicine era: lung cancer as a case study. |
| Q30248745 | Biomarkers of genome instability and cancer epigenetics. |
| Q42151956 | Chromatin patterns associated with lung adenocarcinoma progression |
| Q35088670 | Classification of non-small cell lung cancer based on copy number alterations |
| Q34013428 | Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA |
| Q34534035 | Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer |
| Q35290271 | Correlation between familial cancer history and epidermal growth factor receptor mutations in Taiwanese never smokers with non-small cell lung cancer: a case-control study |
| Q92510114 | Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans |
| Q35753633 | Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinoma |
| Q64267086 | Disentangling tobacco-related lung cancer-genome-wide interaction study of smoking behavior and non-small cell lung cancer risk |
| Q28740835 | Dissecting cis regulation of gene expression in human metabolic tissues |
| Q46653404 | EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women |
| Q34776412 | Effect of single nucleotide polymorphism Rs189037 in ATM gene on risk of lung cancer in Chinese: a case-control study |
| Q36487146 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk |
| Q64939617 | Extracting predictors for lung adenocarcinoma based on Granger causality test and stepwise character selection. |
| Q36592419 | Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations |
| Q33352142 | Filtering the genes and sorting the glomerular filter: a new piece in the puzzle? |
| Q64929118 | Fine Mapping in Chromosome 3q28 Identified Two Variants Associated with Lung Cancer Risk in Asian Population. |
| Q36326842 | Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus |
| Q38043172 | Future Trends in Lung Cancer Diagnosis |
| Q41786499 | GPC5 Gene and Its Related Pathways in Lung Cancer |
| Q84675270 | GPC5 and lung cancer in multiple sclerosis |
| Q46365378 | GPC5 rs2352028 polymorphism and risk of lung cancer in Han Chinese |
| Q43012778 | GPC5 rs2352028 variant and risk of lung cancer in never smokers |
| Q61180898 | GPC5 rs2352028 variant and risk of lung cancer in never smokers – Authors' reply |
| Q40764161 | GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma |
| Q37270019 | GWAS meets TCGA to illuminate mechanisms of cancer predisposition. |
| Q36153364 | Gender-based impact of epidermal growth factor receptor mutation in patients with nonsmall cell lung cancer and previous tuberculosis |
| Q26764865 | Gene mutation discovery research of non-smoking lung cancer patients due to indoor radon exposure |
| Q26862431 | Genetic Predisposition to Chronic Obstructive Pulmonary Disease and/or Lung Cancer: Important Considerations When Evaluating Risk |
| Q36148775 | Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer |
| Q35963119 | Genetic Variants on 15q25.1, Smoking, and Lung Cancer: An Assessment of Mediation and Interaction |
| Q36925216 | Genetic evidence linking lung cancer and COPD: a new perspective |
| Q24606717 | Genetic susceptibility to lung cancer and co-morbidities |
| Q26852320 | Genetic susceptibility to lung cancer--light at the end of the tunnel? |
| Q37800567 | Genetics of lung-cancer susceptibility |
| Q37037246 | Genome-Wide Association Study of Genetic Predictors of Overall Survival for Non–Small Cell Lung Cancer in Never Smokers |
| Q36917140 | Genome-Wide Association Study of Lung Cancer in Korean Non-Smoking Women |
| Q34558036 | Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese |
| Q37045796 | Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy |
| Q90714959 | Genome-wide association study using diversity outcross mice identified candidate genes of pancreatic cancer |
| Q64975021 | Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer. |
| Q39107657 | Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer |
| Q40217330 | Glypican-5 is a tumor suppressor in non-small cell lung cancer cells |
| Q37694835 | Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a |
| Q58705289 | Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression |
| Q28657828 | Heparan sulfate signaling in cancer |
| Q38651957 | High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification |
| Q36695173 | Homogeneous case subgroups increase power in genetic association studies |
| Q36255653 | Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia |
| Q33567579 | Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients |
| Q24595630 | Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers |
| Q37798946 | Induction of Epigenetic Alterations by Dietary and Other Environmental Factors |
| Q34076429 | Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy |
| Q34539540 | Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer |
| Q36258075 | Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions |
| Q90157503 | Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region |
| Q38669269 | Lung Cancer in Never Smokers |
| Q24630167 | Lung Cancer: Epidemiology, Etiology, and Prevention |
| Q28386853 | Lung cancer in never smokers |
| Q55342417 | Lung cancer in never smokers from the Princess Margaret Cancer Centre. |
| Q37998646 | Lung cancer in never smokers – A review |
| Q37944937 | Lung cancer in never smokers. |
| Q34362241 | Lung cancer in never smokers: Disease characteristics and risk factors |
| Q44539648 | Lung cancer in never smokers: a new hot area of research |
| Q39741320 | Lung cancers unrelated to smoking: characterized by single oncogene addiction? |
| Q34091855 | Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development |
| Q34993703 | Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer |
| Q89585803 | Multiple genome pattern analysis and signature gene identification for the Caucasian lung adenocarcinoma patients with different tobacco exposure patterns |
| Q37536837 | Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease |
| Q64039545 | Pathogenic Variants in GPC4 Cause Keipert Syndrome |
| Q37088999 | Performance of an item response theory-based computer adaptive test in identifying functional decline |
| Q35590957 | Polymorphisms in C-reactive protein and Glypican-5 are associated with lung cancer risk and Gartrokine-1 influences Cisplatin-based chemotherapy response in a Chinese Han population. |
| Q47254894 | Polymorphisms in genes related to epithelial-mesenchymal transition and risk of non-small cell lung cancer |
| Q51589742 | Prediction of cancer prognosis with the genetic basis of transcriptional variations |
| Q36808416 | Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study |
| Q34570834 | Primary Lung Adenocarcinomas in Children and Adolescents Treated for Pediatric Malignancies |
| Q37461909 | Prioritization of SNPs for Genome-Wide Association Studies Using an Interaction Model of Genetic Variation, Gene Expression, and Trait Variation |
| Q41078073 | Prognostic significance of GPC5 expression in patients with prostate cancer |
| Q37775627 | Prospects for molecular staging of non-small-cell lung cancer from genomic alterations |
| Q35599740 | Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors. |
| Q36816444 | Proteoglycans and their roles in brain cancer |
| Q39416722 | Rationale and Design of the Japan Molecular Epidemiology for Lung Cancer Study |
| Q44822764 | Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. |
| Q93068318 | SNPs in LncRNA genes are associated with non-small cell lung cancer in a Chinese population |
| Q47561797 | Screening for Lung Cancer: Who Should Be Screened? |
| Q33703646 | Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China. |
| Q37990779 | Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. |
| Q34586191 | Susceptibility loci for lung cancer are associated with mRNA levels of nearby genes in the lung. |
| Q34210728 | The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations |
| Q35208501 | The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration |
| Q36580787 | The Minnesota Center for Twin and Family Research genome-wide association study |
| Q34988362 | The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer |
| Q42075639 | The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer |
| Q51811743 | Using phenotypic heterogeneity to increase the power of genome-wide association studies: application to age at onset of ischaemic stroke subphenotypes |
| Q37574431 | Variants in Inflammation Genes Are Implicated in Risk of Lung Cancer in Never Smokers Exposed to Second-hand Smoke |
| Q41613396 | WNT signaling - lung cancer is no exception. |
| Q37307499 | Women and lung cancer: what is new? |
Search more.